EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cervical cancer patients' vaginal microbiome and metabolites: research progress and clinical applications

Qian Huang, Li Yi Zhang, Hui Lin Shu, Na Chen, Rong Hua Li, Feng Xi Jiang, Guang Ming Li, Mei Pu, Qian Zhang, Yu Lian Gao, Yan Peng Chu

Frontiers in Microbiology · 14.08.2026 · 17

DOI: 10.3389/fmicb.2026.1891111 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 14.08.2026. Verfasst von Qian Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, Ningxia, China. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the fourth most common malignancy among women globally, cervical cancer is intimately linked to persistent high-risk human papillomavirus (HPV) infection; however, HPV infection is not the sole pathogenic factor. Recent studies have revealed that the composition, dynamics, and metabolic products of the vaginal microbiota play pivotal roles in the occurrence, progression, diagnosis, and treatment of cervical cancer. This article offers a comprehensive narrative review of foundational research on the vaginal microbiome in cervical cancer patients, correlations with metabolites, epidemiological characteristics, diagnostic applications, therapeutic strategies, and ongoing controversies and challenges. Basic research demonstrates that increased vaginal microbial diversity and reduced Lactobacillus abundance are associated with cervical cancer progression, wherein pathogenic bacteria such as Fusobacterium spp. and Sneathia spp. have been associated with tumorigenesis through immunosuppression and inflammatory mechanisms. Metabolites like 3-hydroxybutyrate and sphingolipids show potential as diagnostic biomarkers and therapeutic targets. Epidemiological studies reveal associations between variations in the vaginal microbiota across different populations (e.g., African, Latina) and cervical cancer risk. In diagnostics, detection methods based on the vaginal microbiome can enhance early screening efficiency, with novel sequencing technologies combined with artificial intelligence demonstrating promising application prospects. Therapeutically, interventions such as probiotics and microbiota modulation may improve patient outcomes. Nonetheless, current research faces challenges, including an unclear causal relationship between the microbiota and HPV infection and a lack of standardization in detection techniques. Future endeavors necessitate multi-omics integration, large-scale longitudinal studies, and precise intervention strategies to facilitate the clinical translation of vaginal microbiome research into cervical cancer prevention and treatment.

Schlagwörter

Stichwörter der Autor:innen

Lactobacillusbiomarkerscervical cancermetabolitespathogenesisprobioticsvaginal microbiota

Autor:innen und Institutionen

  • Department of Immunology, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, Ningxia, China.
  • Dazhou Vocational and Technical College, Dahzou, Sichuan, China.
  • Department of Obstetrics and Gynecology, Dazhou Central Hospital, Dahzou, Sichuan, China.
  • Department of Pediatrics, Dazhou Hospital of Integrated Chinese and Western Medicine, Dahzou, Sichuan, China.
  • School of Clinical Medicine, Southwest Medical University, Luzhou, Sichuan, China.
  • Department of Cardiology, Dazhou Central Hospital, Dazhou, Sichuan, China.

Zitieren

APA

Huang, Q., Zhang, L. Y., Shu, H. L., Chen, N., Li, R. H., Jiang, F. X., Li, G. M., Pu, M., Zhang, Q., Gao, Y. L., & Chu, Y. P. (2026). Cervical cancer patients' vaginal microbiome and metabolites: research progress and clinical applications. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1891111

Vancouver

Huang Q, Zhang LY, Shu HL, Chen N, Li RH, Jiang FX, et al. Cervical cancer patients' vaginal microbiome and metabolites: research progress and clinical applications. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1891111

BibTeX
@article{Huang2026,
  author = {Huang, Qian and Zhang, Li Yi and Shu, Hui Lin and Chen, Na and Li, Rong Hua and Jiang, Feng Xi and Li, Guang Ming and Pu, Mei and Zhang, Qian and Gao, Yu Lian and Chu, Yan Peng},
  title = {Cervical cancer patients' vaginal microbiome and metabolites: research progress and clinical applications},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1891111}
}
Kostenlos starten →